Snyder Ruth, Herdt Aimee, Mejias-Cepeda Nancy, Ladino John, Crowley Kathryn, Levy Philip
Pediatrics, Goryeb Children's Hospital/Atlantic Health System, Morristown, NJ, USA; MidAtlantic Neonatology Associates, Morristown, NJ, USA.
Pediatrics, Goryeb Children's Hospital/Atlantic Health System, Morristown, NJ, USA.
Pediatr Neonatol. 2017 Dec;58(6):534-540. doi: 10.1016/j.pedneo.2017.04.003. Epub 2017 May 10.
Oropharyngeal colostrum (OC) application strategies have been shown to be feasible and safe for very low birth weight (VLBW) infants. Evidence to support the nutritional and clinical advantages of OC care remains somewhat theoretical. The objectives of this study were to a) confirm the feasibility and safety of OC application in preterm infants and b) determine if OC application is associated with improved nutritional and clinical outcomes from birth to discharge. We hypothesized that OC application in the first few days would promote sustained breast milk feedings through discharge.
An observational longitudinal study was conducted in 133 VLBW infants during 2013-14, after an OC protocol was adopted. Maternal and infant characteristics, infant vital signs during administration, nutritional outcomes, and common neonatal morbidities were assessed and compared to 85 age- and weight-matched VLBW infants from a retrospective control cohort from 2012, prior to the implementation of the OC protocol.
There were no adverse events or changes in vital signs during the application of OC. VLBW infants who received OC continued to receive the majority of their enteral feeds from human breast milk at six 6 of age and through discharge (p < 0.01). There was no difference in maternal characteristics known to affect breast milk production, and rates of common neonatal morbidities were statistically similar between groups.
OC application for VLBW infants is safe and practical in a neonatal intensive care unit setting and is associated with increased rates of breast milk feeding.
口咽初乳(OC)应用策略已被证明对极低出生体重(VLBW)婴儿是可行且安全的。支持OC护理在营养和临床方面优势的证据仍有些理论性。本研究的目的是:a)确认OC应用于早产儿的可行性和安全性;b)确定OC应用是否与从出生到出院时营养和临床结局的改善相关。我们假设在出生后的头几天应用OC将促进持续母乳喂养直至出院。
在2013 - 2014年期间,对133名VLBW婴儿进行了一项观察性纵向研究,此前已采用OC方案。评估了母婴特征、给药期间婴儿生命体征、营养结局和常见新生儿疾病,并与2012年OC方案实施前回顾性对照队列中的85名年龄和体重匹配的VLBW婴儿进行了比较。
OC应用期间未发生不良事件,生命体征也无变化。接受OC的VLBW婴儿在6个月龄时及出院时,大部分肠内喂养仍继续采用母乳(p < 0.01)。已知影响母乳分泌的母亲特征方面无差异,两组间常见新生儿疾病发生率在统计学上相似。
在新生儿重症监护病房环境中,对VLBW婴儿应用OC是安全可行的,且与母乳喂养率增加相关。